UIAA Mountain Medical Centre Information Sheet 1 MOUNTAIN SICKNESS, EDEMAS & TRAVEL TO HIGH ALTITUDES
Introduction A family of related medical conditions that sometimes develop when people travel to altitudes above 3500m (11,500ft), at times even lower. There is a wide variation in both the speed of onset, the severity of symptoms and also at the height at which they occur – this is different for each person. The problems are caused by lack of oxygen. Acute Mountain Sickness Most people feel at least a little unwell if they drive, fly or travel by train from sea level to 3500m. Headache, fatigue, undue breathlessness on exertion, the sensation of the heart beating forcibly, loss of appetite, nausea, vomiting, dizziness, difficulty sleeping and irregular breathing during sleep are the common complaints. These are symptoms of Acute Mountain Sickness (AMS), which usually develop during the first 36 hours at altitude and not immediately on arrival. Well over 50% of travellers develop some form of AMS at 3500m, but almost all do so if they ascend rapidly to 5000m (16,400ft). Acclimatisation Usually, these unpleasant effects of lack of oxygen wear off over two to three days, particularly if no further ascent is made. Once the body has acclimatised in this way, further gradual height gain is possible although symptoms may recur at any time. The question "How high, how fast?" has no absolute answer because of individual variation, but it is reasonable for healthy people of any age to travel rapidly to 3500m, though many will develop some degree of AMS after arrival. It is unwise to travel much above 3500m immediately from sea level. Above 3500m, the speed of further height gain should be gradual and we advise no more than a 300m increase in sleeping altitude per day (with a rest day every third day) and spending at least a week above 3500m before sleeping at 5000m. This does not mean you can’t ascend more than 300m in a day (eg. to cross a pass or attempt a summit), as long as you descend again before sleeping. The highest altitude where man lives permanently is about 5500m (18,000ft) but on mountaineering expeditions or a trek, residence for several weeks around 6000m (20,000ft) is quite possible and at these altitudes one should feel entirely well when acclimatised, being limited only by breathlessness on exertion. Prediction of AMS There is unfortunately no way of predicting whom AMS will seriously trouble and who will escape it. It is tempting to suppose that being physically fit and avoiding smoking would help in prevention but unfortunately, this does not seem to be the case. Similarly, if you have previously been affected (or not), it seems no more or less likely that you will avoid AMS the next time you travel to altitude. Strenuous exercise at altitude, whether or not the subject is fit, makes AMS worse; undue exertion and heavy loads should therefore be avoided until acclimatised. Patients with heart or lung disease or high blood pressure should seek specialist advice before travelling above 4000m. Prevention of AMS: Diamox (acetazolamide) There has been much research on Diamox, a drug used to reduce fluid retention (it makes you urinate). There is no doubt that Diamox is genuinely useful in the prevention of Acute Mountain Sickness if taken for several days before ascent, however it is not without it’s dangers. If people really want to take this as a prophylactic medication, I usually give 125mg Diamox twice daily for 3 days before ascent to 3500m (or more), and for two more days - i.e.
five days in all. Exactly how it works is unknown, but its effect on breathing (it makes breathing faster and deeper in sleep) may be more important than its direct effect on the output of urine. Travellers who choose to take Diamox should be aware of its unwanted effects - for all drugs have their dangers. Some people feel nauseated and generally unwell, and tingling of the fingers is quite common. More unusual side effects include flushing, rashes, thirst, drowsiness or undue excitement, and occasional serious allergic reactions - although these cease when the drug is stopped. A test day (or two) of Diamox at sea level well before a trip is sometimes helpful. It should be noted that Diamox is not recommended as a routine drug before any ascent: many mountaineers and trekkers prefer to do without it (I do not usually take it myself). The important point to understand is that it only relieves the symptoms of AMS and will not prevent the condition worsening should a sufferer fail to descend or rest. Thus its routine use to before, or to allow continued or rapid ascent is extremely dangerous, possibly masking warning signs (symptoms) of more serious HAPE and HACE and allowing ascent to a point where subsequent descent is difficult or impossible. Diamox should only be used for the relief of AMS in a controlled fashion, to allow descent and rest - the only cure for AMS. Prevention of AMS: Hypoxic Training Over the years there have been various attempts to train in a hypoxic environment – other than going high, which is obviously the simplest advice. Recently, a hypoxic tent has been marketed in the US, however we have no information about the efficiency, safety or cost of the system, and would welcome information from anyone who has used it. For more information, contact: Hypoxico Inc 50 Lexington Avenue, Suite 249 New York, NY 10010 Tel: 001-212-726-3654 Fax: 001-212-213-3247
Treatment of AMS It is important to emphasise that Acute Mountain Sickness, though unpleasant, is usually a self-limiting condition without serious long-term consequences. Aspirin, Panadol (paracetamol), or Neurofen help the headache, and drugs used for travel sickness such as Avomine (promethazine), Stemetil (prochlorperazine) and Stugeron (cinnarizine) may help the nausea and dizziness. Dexamethasone (a steroid) is also used. Oxygen by mask also helps the symptoms, as does use of a portable altitude compression (PAC) chamber. Personally, I tend to use no drugs (apart from oxygen) unless really necessary because the symptoms usually resolve: the only cure is to rest, become acclimatised to the lack of oxygen and if necessary descend. The most important treatment is not to go higher if one has symptoms and to consider losing altitude if either recovery does not take place within several days - and certainly, if symptoms become steadily worse. Severe Forms of AMS: High Altitude Pulmonary and Cerebral Edema (HAPE & HACE) In less than 2% of travellers AMS occurs in several serious forms at 4000-5000m and occasionally lower. High Altitude Pulmonary Oedema is one, in which fluid accumulates in the lungs and causes severe illness (which may come on in minutes) recognised by breathlessness and sometimes a bubbling sound in the chest.
Early pulmonary oedema should be suspected if breathlessness at rest occurs or if someone has what appears to be a persistent cough or chest infection causing breathlessness. Patients with pulmonary edema are dangerously ill and should be treated as an emergency and evacuated to a lower altitude. Frequently a descent of only 500m is sufficient to improve the situation dramatically. Oxygen by mask is especially helpful, as are PAC chambers, Nifedipine, Diamox and steroid drugs (see below).
High Altitude Cerebral Edema is another form of AMS, thankfully also a relative rarity. It is due to fluid collecting within the brain causing the victim to become irrational, drowsy and confused over a period of hours - their walking will become unsteady and double vision, headaches and vomiting may occur. Again, the condition is a serious one and evacuation to low altitudes mandatory. Steroid drugs such as Dexamethasone (Decadron) are used in treatment, in addition to oxygen and/or a PAC chamber. In both these conditions, medical advice is desirable though it may well not be available. Anyone suspected of having pulmonary or cerebral oedema should be evacuated to lower altitude promptly and should certainly not go high again until a doctor has seen them. Complete recovery from both conditions is usual if the casualty is treated early and appropriately. Peripheral Oedema & Retinal Haemorrhages Fluid retention causing swelling of the face, an arm or a leg is sometimes noticed on waking or after a long march - this is peripheral oedema. The condition usually subsides over several days and does not herald pulmonary or cerebral oedema. Haemorrhages into the retina (minute blood blisters in the back of the eye) are known to occur quite commonly around 5000m but very rarely cause any problems, being unnoticed by the subject and visible only to a trained observer with specialist equipment (an ophthalmoscope). Very occasionally, these tiny haemorrhages interfere with vision (causing a "hole in the vision") – if affected descent is advised, and complete recovery is usual though not invariable. Summary Acute Mountain Sickness is a common and minor, though debilitating problem at high altitude. Rarely, it leads to two potentially fatal conditions – High Altitude Pulmonary and Cerebral Oedema (HAPE & HACE) - both of which are medical emergencies. In giving advice about travel to high altitudes it must be stressed that the simple adage of gaining height slowly and descending promptly if one is ill - advice known for generations in all high countries - cannot be bettered. More detailed notes about treatment of all forms of AMS follow. TREATMENT OF AMS, PULMONARY AND CEREBRAL OEDEMA
Mild AMS 1.
Drugs for nausea & vomiting (see text - they are often unhelpful)
Severe AMS/High Altitude Cerebral Oedema 1.
Dexamethasone 8 mg by mouth followed by 4 mg every 6 hours for 24 hours
Diamox (acetazolamide) 125-250mg twice daily for 3 days
High Altitude Pulmonary Oedema 1.
Nifedipine 20 mg by mouth + 20 mg every 6 hours for 24 hours
Severe Altitude Illness,type unknown
No harm is likely if all treatments are given:
NOTE: The potential unwanted side effects of the drugs mentioned above (listed above and in sheet 3) should be considered before their use.
The UIAA Mountain Medicine Centre is supported by:
International Union of Alpine Associations (UIAA) Dr Charles Clarke FRCP Updated October 2002 UIAA Mountain Medicine Centre
Appendix 9: Tier II at-risk species. Tier II species include those that did not meet the Tier I criteria but were ranked by the Nebraska Natural Heritage Program as either State Critically Imperiled (S1), State Imperiled (S2) or State Vulnerable (S3) (see appendix 4 for explanation of ranks). Because of the large number of at-risk plant species, only those species listed as S1 or S2 are
Promemoria Planering av arbetsskiftsförteckning i periodarbetstid enligt bestämmelserna i arbetstidslagen och det allmänna kommunala tjänste- och arbetskollektiv- avtalet (AKTA) Tillämpning av systemet för periodarbetstid Hur en arbetsskiftsförteckning upprättas Att iaktta och ändra arbetsskiftsförteckningen 6.1 Arbetsgivarens rätt att av grundad anledning ensidigt 6.2